| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2011976 | Pharmacological Reports | 2015 | 6 Pages |
Abstract
The presented results indicate that aliskiren inhibits hemostasis in the arterial thrombosis in rats. The antithrombotic effect is related with improvement of the fibrinolytic balance, and also depends on antiplatelet action.
Keywords
SBPHCTRASMCHPLTvWFPAI-1WBCICAM-1NADPHPRAANPMCHCAPTTRBCMCVASAVCAM-1AT1 receptor antagonistst-PA2K-1CNG-nitro-l-arginine methyl esterPGI2ARBsl-NAMEAspirinaliskirenAngiotensin converting enzyme inhibitorsAngiotensin IIplasminogen activator inhibitorArterial thrombosisred blood cell counttumor necrosis factor alphaMean corpuscular volumeAng IIactivated partial thromboplastin timethrombin timeprothrombin timeRenin–angiotensin systemWhite blood cell countTissue factorVon Willebrand factorsystolic blood pressuremean arterial pressuretissue plasminogen activatorPlasma renin activityFibrinogenmean corpuscular hemoglobinRatsvascular cell adhesion molecule-1Mean corpuscular hemoglobin concentrationmapNitric oxidehematocritHemoglobinHgbvehVehiclehemostatic parametersprostacyclinPlateletatrial natriuretic peptide
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Justyna Magdalena Hermanowicz, Piotr Buczko, Anna Tankiewicz-Kwedlo, Adam Hermanowicz, Wlodzimierz Buczko,